Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic or orthopedic industry newsletters.

Ophthalmic Orthopedic

Recently Added ophthalmic

COVID 19OphthalmicRefractiveSurgery
LVI, TLC Management Firm Files for Bankruptcy as it Seeks New Ownership

Vision Group Holdings, the management company that oversees The LASIK Vision Institute (LVI) and TLC Laser Eye Centers (TLC), filed for bankruptcy protection May 29 due to the pandemic-related shut...

Bausch + Lomb Announces European Launch of LuxSmart and LuxGood Preloaded IOLs

Bausch + Lomb announced May 27 the European launch of LuxSmart, the company's first extended depth of focus (EDOF) intraocular lens (IOL), and LuxGood, a new monofocal IOL. Both feature preload...

Mynosys, Maker of Zepto Platform, Changes Name to Centricity

Mynosys Cellular Devices, of Carlsbad, California, announced May 27 that it was changing its name to Centricity Vision. The maker of the Zepto capsulotomy platform said the change conveys the compa...

BreakingClinical TrialOphthalmicPharmaRetina
Port Delivery System with Ranibizumab Shows Positive Phase III Results in Wet AMD

Genentech, a member of the Roche Group, on May 27 released positive topline results from the Phase III Archway study, evaluating its Port Delivery System (PDS) with ranibizumab in patients with wet...

Roche Acquires Stratos Genomics to Further Develop DNA Sequencing for Diagnostic Use

Swiss drugmaker Roche announced May 22 that it had acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. Using nanopore s...

American BriVision Raises $2 Million in Private Placement

American BriVision reported May 21 that it had raised $2 million after more than doubling its private placement to 890 thousand common shares at $2.25 per share to meet unexpected demand. Each inve...

Outlook Therapeutics Raises $16 Million in Private Placement

Outlook Therapeutics announced May 26 that it had raised $16 million through a private placement of common stock with investment firm Syntone Ventures, a US subsidiary of China-based Syntone Techno...

Sanofi to Sell $13.2 Billion Regeneron Stake; Companies Will Continue to Collaborate

Paris-based drugmaker Sanofi announced May 25 that it would sell 12.8 million shares of Regeneron common stock, a stake worth more than $7 billion based on May 22’s closing price of $569.91, in a r...

Xbrane Raises $15 Million to Advance Xlucane

Xbrane announced May 20 that it had raised more than $15 million (SEK 146 million) in a directed share issue. The offering comprised 3,853,799 shares at about $4 per share and was heavily oversubsc...

BreakingDry EyeOphthalmicPharmaRegulation
FDA Accepts Kala’s New Drug Application for Eysuvis for Dry Eye Disease

Kala Pharmaceuticals announced May 26 that the US FDA had accepted for review the company’s new drug application (NDA) resubmission for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% f...

BreakingDry EyeOphthalmicRegulation
Sonoma Gains CE Marking for Blepharitis Lid and Lash Spray

Sonoma Pharmaceuticals announced May 26 that it had received CE marking for its Microdacyn60 hypochlorous acid lid and lash formulation. The product, marketed in the US as Acuicyn, aims to keep are...

COVID 19CataractMeetingNewsletterOphthalmicRefractive
ASCRS is First Ophthalmic Group to Pull Off Major Virtual Meeting During Pandemic

The American Academy of Cataract and Refractive Surgery took the plunge first in holding an all-virtual meeting May 16-17 after originally canceling its meeting in Boston due to the COVID-19 pandem...

Past News Stories

COVID 19MeetingNewsletterOphthalmicSurgical
New COVID-19 Survey Series: Premium IOL Volume Faces Challenges in Rebounding

Results from Part 1 of Market Scope’s COVID-19 US Practice Impact Survey reveal that nearly 41 percent of surgeons expect a decrease in premium IOL conversion once the COVID-19 pandemic subsides. T...

PC-IOL Market Penetration Lags Despite Flurry of New Options

The market share for presbyopia-correcting intraocular lenses (PC-IOLs) has remained relatively flat over the last three years, despite a dizzying array of novel extended depth of focus (EDOF) and ...

Q1-2020 Ophthalmic Deals Reveal Continued Interest in Retinal Therapies, Dry Eye Treatments

Ophthalmic deals garnered over $2.4 billion in the first quarter of 2020, driven largely by dry eye and retina related fundraising. Twenty-one unique transactions occurred during this period, and 6...

COVID 19CataractNewsletterOphthalmicSurgical
Pandemic Leaves Backlog of Millions of Ophthalmic Surgeries

Ophthalmic elective procedures came to an abrupt halt for six to eight weeks in most markets, creating backlogs of surgical candidates. Many US states now allow elective surgery at outpatient facil...

ASCRS Speakers Analyze Latest Cataract Products, Status of Same-Day Surgery

This year’s meeting of the American Society of Cataract and Refractive Surgery (ASCRS)—a condensed, online version of the event due to the pandemic—focused on advances in cataract surgery to offer ...

ASCRS Presenters Showcase Innovations in Cornea Treatments

Advances in cornea disease management and transplant technologies were heavily discussed at the virtual 2020 ASCRS meeting, with the topics leading off a keratoconus symposium on Saturday afternoon...

COVID 19GlaucomaNewsletterOphthalmicRetina
COVID-19 News Briefs for May 2020

The American Academy of Ophthalmology (AAO) is considering three options for its annual meeting, scheduled for Nov. 13–17 in Las Vegas, according to George Williams, the AAO’s immediate past presid...

BreakingCOVID 19MeetingNewsletterOphthalmic
Market Scope Lists 2020 Ophthalmic Meetings Canceled, Delayed Due to COVID-19

Market Scope is tracking the status of 2020 ophthalmic meetings worldwide as the COVID-19 outbreak spreads. Several conferences have been delayed or canceled outright. Here is the latest informatio...

Novartis Acquires Amblyotech, Maker of Digital Therapy for Lazy Eye

Swiss drugmaker Novartis announced April 20 that it had acquired Amblyotech, a US-based software startup developing digital technology for the treatment of amblyopia, or “lazy eye.” In a news relea...

Ziemer’s Femto LDV Z8 Gains Indications for Lenticule Extraction, Children’s Cataract Surgery

Swiss company Ziemer reported April 27 that it had gained CE marking for two new applications using its Femto LDV Z8 Laser Platform. The first application is called CLEAR, short for corneal lenticu...

AbbVie Completes Its $63 Billion Allergan Purchase

AbbVie has completed its $63 billion acquisition of Allergan, the maker of Botox and an extensive eye care portfolio, the company announced May 8. Allergan’s eye products will become part of AbbVie...

COVID 19DiagnosticNewsletterOphthalmic
Market Scope Weekly Ophthalmic Surgeon and Industry Polls for May 2020

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2020 Market Scope, LLC. All Rights reserved.